Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 5 (2008), Issue 3 (March)

1. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies.
   Lancet, 371(9614): 736-43. [Abstract] [Full-text]
2. Intrauterine risk factors for precocious atherosclerosis.
   Pediatrics, 121(3): 570-4. [Abstract] [Full-text]
3. Detection of hypoglycemia by children with type 1 diabetes 6 to 11 years of age and their parents: a field study.
   Pediatrics, 121(3): e489-95. [Abstract] [Full-text]
4. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
   Pediatrics, 121(3): e466-72. [Abstract] [Full-text]
5. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.
   BMJ, 336(7642): 491-5. [Abstract] [Full-text]
6. Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats.
   Biochem Biophys Res Commun, 368(3): 528-35. [Abstract] [Full-text]
7. Initiating statins in the elderly: the evolving challenge.
   Curr Opin Endocrinol Diabetes Obes, 15(2): 182-7. [Abstract] [Full-text]
8. Gastrointestinal surgery as treatment for type 2 diabetes.
   Curr Opin Endocrinol Diabetes Obes, 15(2): 153-8. [Abstract] [Full-text]
9. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
   Curr Opin Endocrinol Diabetes Obes, 15(2): 147-52. [Abstract] [Full-text]
10. Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.
    Curr Opin Endocrinol Diabetes Obes, 15(2): 142-6. [Abstract] [Full-text]
11. Diabetes mellitus and inflammatory periodontal diseases.
    Curr Opin Endocrinol Diabetes Obes, 15(2): 135-41. [Abstract] [Full-text]
12. Ethnic disparities in diabetes care: myth or reality?
    Curr Opin Endocrinol Diabetes Obes, 15(2): 128-34. [Abstract] [Full-text]
13. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease?
    Curr Opin Endocrinol Diabetes Obes, 15(2): 123-7. [Abstract] [Full-text]
14. Sensor-augmented pump therapy in type 1 diabetes.
    Curr Opin Endocrinol Diabetes Obes, 15(2): 118-22. [Abstract] [Full-text]
15. The rough road for rosiglitazone.
    Curr Opin Endocrinol Diabetes Obes, 15(2): 113-7. [Abstract] [Full-text]
16. Sitagliptin: a novel agent for the management of type 2 diabetes mellitus.
    Am J Health Syst Pharm, 65(6): 521-31. [Abstract] [Full-text]
17. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.
    Ophthalmology, 115(3): 533-539.e2. [Abstract] [Full-text]
18. Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography.
    Ophthalmology, 115(3): 525-32. [Abstract] [Full-text]
19. Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patients with autoimmune diabetes mellitus.
    Autoimmunity, 41(2): 143-53. [Abstract] [Full-text]
20. Glial cell line-derived neurotrophic factor increases beta-cell mass and improves glucose tolerance.
    Gastroenterology, 134(3): 727-37. [Abstract] [Full-text]
21. High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.
    J Intern Med, 263(4): 440-9. [Abstract] [Full-text]
22. Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002.
    J Intern Med, 263(4): 386-94. [Abstract] [Full-text]
23. Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study.
    J Intern Med, 263(4): 376-85. [Abstract] [Full-text]
24. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.
    Am J Med, 121(3): 246.e1-8. [Abstract] [Full-text]
25. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Expert Rev Cardiovasc Ther, 6(3): 343-68. [Abstract] [Full-text]
26. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Expert Rev Cardiovasc Ther, 6(3): 323-41. [Abstract] [Full-text]
27. Early-onset Type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk.
    Expert Rev Cardiovasc Ther, 6(3): 315-22. [Abstract] [Full-text]
28. Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial).
    Am J Cardiol, 101(6): 796-800. [Abstract] [Full-text]
29. Is thyroid autoimmunity associated with gestational diabetes mellitus?
    Metabolism, 57(4): 522-5. [Abstract] [Full-text]
30. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients.
    Metabolism, 57(4): 479-87. [Abstract] [Full-text]
31. Predictors of glycemic control in Japanese subjects with type 2 diabetes mellitus.
    Metabolism, 57(4): 453-7. [Abstract] [Full-text]
32. Is albuminuria an indicator of myocardial dysfunction in diabetic patients without overt heart disease? A study with Doppler strain and strain rate imaging.
    Metabolism, 57(4): 448-52. [Abstract] [Full-text]
33. Use of oral glucose minimal model-derived index of insulin sensitivity in subjects with early type 1 diabetes mellitus.
    Metabolism, 57(4): 445-7. [Abstract] [Full-text]
34. Development of beta-cells in the native pancreas after pancreas allo-transplantation in the Spontaneously Diabetic Torii rat.
    J Surg Res, 145(2): 229-37. [Abstract] [Full-text]
35. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.
    Fertil Steril, 89(3): 625-34. [Abstract] [Full-text]
36. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Fertil Steril, 89(3): 649-55. [Abstract] [Full-text]
37. Development and validation of an all-cause mortality risk score in type 2 diabetes.
    Arch Intern Med, 168(5): 451-7. [Abstract] [Full-text]
38. The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus.
    Pharmacogenet Genomics, 18(4): 369-72. [Abstract] [Full-text]
39. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
    Pharmacogenet Genomics, 18(4): 279-87. [Abstract] [Full-text]
40. Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs.
    Int J Exp Pathol, 89(2): 125-37. [Abstract] [Full-text]
41. Functional analysis of the zinc finger and activation domains of Glis3 and mutant Glis3(NDH1).
    Nucleic Acids Res, 36(5): 1690-702. [Abstract] [Full-text]
42. The duration of severe insulin omission is the factor most closely associated with the microvascular complications of Type 1 diabetic females with clinical eating disorders.
    Int J Eat Disord, 41(3): 259-64. [Abstract] [Full-text]
43. Impaired endothelial function in adolescents with type 1 diabetes mellitus.
    J Pediatr, 152(4): 557-62. [Abstract] [Full-text]
44. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Expert Opin Pharmacother, 9(5): 669-76. [Abstract] [Full-text]
45. Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication.
    Circulation, 117(11): 1361-8. [Abstract] [Full-text]
46. Plaque characterisation by Virtual Histology intravascular ultrasound analysis in patients with type 2 diabetes.
    Heart, 94(4): 429-33. [Abstract] [Full-text]
47. Diabetes increases p53-mediated apoptosis following ischemia.
    Plast Reconstr Surg, 121(4): 1135-43. [Abstract] [Full-text]
48. Haplotypic analysis of Wellcome Trust Case Control Consortium data.
    Hum Genet, 123(3): 273-80. [Abstract] [Full-text]
49. Inverse association between periodontitis and respiratory allergies in patients with type 1 diabetes mellitus.
    J Clin Periodontol, 35(4): 305-10. [Abstract] [Full-text]
50. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Arterioscler Thromb Vasc Biol, 28(4): 786-91. [Abstract] [Full-text]
51. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells.
    Arterioscler Thromb Vasc Biol, 28(4): 651-7. [Abstract] [Full-text]
52. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
    J Am Coll Cardiol, 51(12): 1181-7. [Abstract] [Full-text]
53. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.
    Nat Clin Pract Endocrinol Metab, 4(4): 200-13. [Abstract] [Full-text]
54. Imbalance in sex hormone levels exacerbates diabetic renal disease.
    Hypertension, 51(4): 1218-24. [Abstract] [Full-text]
55. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Nephrol Dial Transplant, 23(4): 1216-23. [Abstract] [Full-text]
56. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Nephrol Dial Transplant, 23(4): 1346-54. [Abstract] [Full-text]
57. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study.
    Nephrol Dial Transplant, 23(4): 1278-84. [Abstract] [Full-text]
58. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Nephrol Dial Transplant, 23(4): 1436-41. [Abstract] [Full-text]
59. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
    Nephrol Dial Transplant, 23(4): 1274-7. [Abstract] [Full-text]
60. Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model.
    Nephrol Dial Transplant, 23(4): 1166-72. [Abstract] [Full-text]
61. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy.
    Eur J Endocrinol, 158(4): 543-9. [Abstract] [Full-text]
62. Desmopressin increases IGF-binding protein-1 in humans.
    Eur J Endocrinol, 158(4): 479-82. [Abstract] [Full-text]
63. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.
    Pancreas, 36(3): 274-8. [Abstract] [Full-text]
64. Deficient heat shock protein 70 response to stress in leukocytes at onset of type 1 diabetes.
    Biochem Biophys Res Commun, 369(2): 421-5. [Abstract] [Full-text]
65. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.
    Expert Opin Investig Drugs, 17(4): 575-81. [Abstract] [Full-text]
66. 11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity.
    Expert Opin Investig Drugs, 17(4): 481-96. [Abstract] [Full-text]
67. Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population.
    BMC Med Genet, 9: 8. [Abstract] [Full-text]
68. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
    Am Heart J, 155(4): 712-7. [Abstract] [Full-text]
69. The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.
    Am Heart J, 155(4): 640-7. [Abstract] [Full-text]
70. Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy.
    Br J Ophthalmol, 92(4): 552-6. [Abstract] [Full-text]
71. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
    Br J Ophthalmol, 92(4): 548-51. [Abstract] [Full-text]
72. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.
    BMJ, 336(7646): 697-701. [Abstract] [Full-text]
73. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
    Br J Ophthalmol, 92(4): 545-7. [Abstract] [Full-text]
74. Determinants of sexual function among women with type 2 diabetes in a Nigerian population.
    J Sex Med, 5(4): 878-86. [Abstract] [Full-text]
75. Diabetes and asymptomatic carotid stenosis: does diabetic disease influence the outcome of carotid endarterectomy? A 10-year single center experience.
    Surgery, 143(4): 519-25. [Abstract] [Full-text]
76. Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study.
    Diabetes, 57(4): 1147-50. [Abstract] [Full-text]
77. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.
    Diabetes, 57(4): 929-37. [Abstract] [Full-text]
78. Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes.
    Biochem Pharmacol, 75(8): 1649-58. [Abstract] [Full-text]
79. Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.
    Diabetes, 57(4): 889-98. [Abstract] [Full-text]
80. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate.
    Diabetes, 57(4): 841-5. [Abstract] [Full-text]
81. Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.
    Diabetes, 57(4): 1093-100. [Abstract] [Full-text]
82. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families.
    Diabetes, 57(4): 1084-92. [Abstract] [Full-text]
83. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes.
    Diabetes, 57(4): 1018-25. [Abstract] [Full-text]
84. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.
    Diabetes, 57(4): 1108-14. [Abstract] [Full-text]
85. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.
    Diabetes, 57(4): 995-1001. [Abstract] [Full-text]
86. Genetic variants in the UCP2-UCP3 gene cluster and risk of diabetes in the Women's Health Initiative Observational Study.
    Diabetes, 57(4): 1101-7. [Abstract] [Full-text]
87. Targeting of pancreatic glia in type 1 diabetes.
    Diabetes, 57(4): 918-28. [Abstract] [Full-text]
88. Variations of the perforin gene in patients with type 1 diabetes.
    Diabetes, 57(4): 1078-83. [Abstract] [Full-text]
89. A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study.
    Diabetes, 57(4): 1143-6. [Abstract] [Full-text]
90. The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.
    Diabetes, 57(4): 1063-8. [Abstract] [Full-text]
91. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.
    Diabetes, 57(4): 980-6. [Abstract] [Full-text]
92. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.
    Diabetes, 57(4): 1131-5. [Abstract] [Full-text]
93. Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects.
    Diabetes, 57(4): 1136-42. [Abstract] [Full-text]
94. B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes.
    Diabetes, 57(4): 909-17. [Abstract] [Full-text]
95. Activation of central lactate metabolism lowers glucose production in uncontrolled diabetes and diet-induced insulin resistance.
    Diabetes, 57(4): 836-40. [Abstract] [Full-text]
96. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.
    Diabetes, 57(4): 1057-62. [Abstract] [Full-text]
97. HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy.
    Diabetes, 57(4): 1069-77. [Abstract] [Full-text]
98. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.
    Diabetes, 57(4): 945-57. [Abstract] [Full-text]
99. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.
    Diabetes, 57(4): 1026-33. [Abstract] [Full-text]
100. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group.
     Diabetes, 57(4): 1115-9. [Abstract] [Full-text]
101. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients.
     Diabetes, 57(4): 1043-7. [Abstract] [Full-text]
102. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.
     Diabetes, 57(4): 1034-42. [Abstract] [Full-text]
103. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans.
     Diabetes, 57(4): 1048-56. [Abstract] [Full-text]
104. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study.
     Diabetes, 57(4): 809-16. [Abstract] [Full-text]
105. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects.
     Diabetes, 57(4): 1125-30. [Abstract] [Full-text]
106. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.
     Diabetes, 57(4): 1002-17. [Abstract] [Full-text]
107. The progress of coronary heart disease in Type 2 diabetes as measured by coronary calcium score from electron beam computed tomography (EBCT): the PREDICT study.
     Atherosclerosis, 197(2): 777-83. [Abstract] [Full-text]
108. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study.
     Atherosclerosis, 197(2): 931-6. [Abstract] [Full-text]
109. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes.
     Atherosclerosis, 197(2): 883-8. [Abstract] [Full-text]
110. Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation.
     Atherosclerosis, 197(2): 718-24. [Abstract] [Full-text]
111. Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease.
     Atherosclerosis, 197(2): 646-53. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.